Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DFTX · NASDAQ · Medicinal Chemicals & Botanical Products
$28.34−1.14 (−3.87%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Definium Therapeutics (DFTX) · oqro.io/stocks/DFTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office no longer reported DFTX for Q3 2026Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
JANUS HENDERSON GROUP Ltd. now owns 5.4% of DFTX as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Capital World Investors now owns 6.1% of DFTX as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 5, 2026
FMR LLC now owns 6.5% of DFTX as a passive investorSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 30, 2026
CEO sold ~$1.15M of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 30, 2026
Director sold ~$397K of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 30, 2026
Officer sold ~$514K of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 30, 2026
CFO sold ~$123K of DFTX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ra Capital Management, L.P. disclosed a new position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Duquesne Family Office disclosed a new position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Avoro Capital Advisors LLC disclosed an increased position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC disclosed an increased position in DFTX for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Avoro Capital Advisors LLC disclosed a new position in DFTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a new position in DFTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a new position in DFTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a reduced position in DFTX for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Driehaus Capital Management LLC disclosed a new position in DFTX for Q4 2025SourceInsider trade · Traded Sep 25, 2025 · Filed Sep 26, 2025
CEO sold ~$252K of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2025 · Filed Sep 26, 2025
Officer sold ~$110K of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2025 · Filed Sep 26, 2025
Officer sold ~$75K of DFTX shares in the open marketSourceInsider trade · Traded Jun 25, 2025 · Filed Jun 26, 2025
CEO sold ~$180K of DFTX shares in the open marketSourceInsider trade · Traded Jun 25, 2025 · Filed Jun 26, 2025
Officer sold ~$78K of DFTX shares in the open marketSourceInsider trade · Traded Jun 25, 2025 · Filed Jun 26, 2025
Officer sold ~$53K of DFTX shares in the open marketSourceInsider trade · Traded Mar 25, 2025 · Filed Mar 26, 2025
CEO sold ~$143K of DFTX shares in the open marketSourceInsider trade · Traded Mar 25, 2025 · Filed Mar 26, 2025
Officer sold ~$46K of DFTX shares in the open marketSourceInsider trade · Traded Mar 25, 2025 · Filed Mar 26, 2025
Officer sold ~$44K of DFTX shares in the open marketSourceInsider trade · Traded Mar 25, 2025 · Filed Mar 26, 2025
Officer sold ~$16K of DFTX shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 27, 2024
CEO sold ~$142K of DFTX shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 27, 2024
Officer sold ~$49K of DFTX shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 27, 2024
Officer sold ~$34K of DFTX shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 27, 2024
Officer sold ~$17K of DFTX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 30, 2026
Officer sold ~$113K of DFTX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed a reduced position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Eventide Asset Management, LLC disclosed an increased position in DFTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed an increased position in DFTX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed a new position in DFTX for Q1 2026SourceInsider trade · Traded Dec 5, 2024 · Filed Dec 5, 2024
Director purchased ~$18K of DFTX shares in the open marketSource